Golden State Wealth Management LLC Has $1.25 Million Stock Position in Axon Enterprise, Inc (NASDAQ:AXON)

Golden State Wealth Management LLC boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 104.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,376 shares of the biotechnology company's stock after buying an additional 1,213 shares during the quarter. Golden State Wealth Management LLC's holdings in Axon Enterprise were worth $1,250,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in Axon Enterprise by 3.4% in the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock worth $5,019,886,000 after acquiring an additional 275,959 shares during the period. Geode Capital Management LLC grew its position in shares of Axon Enterprise by 3.7% in the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock valued at $1,095,542,000 after purchasing an additional 65,097 shares during the last quarter. Capital World Investors increased its stake in shares of Axon Enterprise by 86.4% in the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock worth $1,079,145,000 after purchasing an additional 841,772 shares during the period. Alliancebernstein L.P. lifted its position in shares of Axon Enterprise by 273.8% during the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock worth $659,128,000 after purchasing an additional 812,337 shares during the last quarter. Finally, Norges Bank bought a new stake in Axon Enterprise during the 4th quarter valued at approximately $482,081,000. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction that occurred on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This represents a 0.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, President Joshua Isner sold 9,000 shares of the company's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $683.31, for a total transaction of $6,149,790.00. Following the sale, the president now directly owns 308,714 shares in the company, valued at $210,947,363.34. This trade represents a 2.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 44,642 shares of company stock worth $30,500,428. Insiders own 4.40% of the company's stock.

Analyst Ratings Changes

Several research firms have recently issued reports on AXON. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Barclays upped their target price on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. The Goldman Sachs Group raised their target price on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. Bank of America boosted their price target on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. Finally, Needham & Company LLC raised their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $699.55.

Axon Enterprise Price Performance

Axon Enterprise stock traded up $8.26 during mid-day trading on Friday, hitting $812.21. 109,501 shares of the company were exchanged, compared to its average volume of 705,383. The company has a market capitalization of $63.23 billion, a PE ratio of 196.19, a price-to-earnings-growth ratio of 90.37 and a beta of 1.29. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. The business has a fifty day moving average of $709.79 and a 200 day moving average of $629.30. Axon Enterprise, Inc has a 1-year low of $279.02 and a 1-year high of $813.63.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The company had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. During the same quarter last year, the business posted $1.15 earnings per share. The company's revenue was up 31.3% on a year-over-year basis. As a group, sell-side analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.